Discovery of Small‐Molecule Inhibitors of the TLR1/TLR2 Complex
Kui Cheng,Xiaohui Wang,Shuting Zhang,Hang Yin
DOI: https://doi.org/10.1002/anie.201204910
2012-01-01
Angewandte Chemie
Abstract:Angewandte Chemie International EditionVolume 51, Issue 49 p. 12246-12249 Communication Discovery of Small-Molecule Inhibitors of the TLR1/TLR2 Complex† Dr. Kui Cheng, Dr. Kui Cheng Department of Chemistry and Biochemistry and the BioFrontiers Institute, University of Colorado at Boulder, Boulder, CO 80309 (USA)Search for more papers by this authorDr. Xiaohui Wang, Dr. Xiaohui Wang Department of Chemistry and Biochemistry and the BioFrontiers Institute, University of Colorado at Boulder, Boulder, CO 80309 (USA)Search for more papers by this authorShuting Zhang, Shuting Zhang Department of Chemistry and Biochemistry and the BioFrontiers Institute, University of Colorado at Boulder, Boulder, CO 80309 (USA)Search for more papers by this authorProf. Dr. Hang Yin, Corresponding Author Prof. Dr. Hang Yin [email protected] Department of Chemistry and Biochemistry and the BioFrontiers Institute, University of Colorado at Boulder, Boulder, CO 80309 (USA)Department of Chemistry and Biochemistry and the BioFrontiers Institute, University of Colorado at Boulder, Boulder, CO 80309 (USA)Search for more papers by this author Dr. Kui Cheng, Dr. Kui Cheng Department of Chemistry and Biochemistry and the BioFrontiers Institute, University of Colorado at Boulder, Boulder, CO 80309 (USA)Search for more papers by this authorDr. Xiaohui Wang, Dr. Xiaohui Wang Department of Chemistry and Biochemistry and the BioFrontiers Institute, University of Colorado at Boulder, Boulder, CO 80309 (USA)Search for more papers by this authorShuting Zhang, Shuting Zhang Department of Chemistry and Biochemistry and the BioFrontiers Institute, University of Colorado at Boulder, Boulder, CO 80309 (USA)Search for more papers by this authorProf. Dr. Hang Yin, Corresponding Author Prof. Dr. Hang Yin [email protected] Department of Chemistry and Biochemistry and the BioFrontiers Institute, University of Colorado at Boulder, Boulder, CO 80309 (USA)Department of Chemistry and Biochemistry and the BioFrontiers Institute, University of Colorado at Boulder, Boulder, CO 80309 (USA)Search for more papers by this author First published: 11 September 2012 https://doi.org/10.1002/anie.201204910Citations: 100 † We thank the U.S. National Institutes of Health (DA026950, DA025740s and NS067425) for financial support of this work. The sTLR2 DNA plasmid was kindly provided by Dr. Chiaki Nishitani and Dr. Yoshio Kuroki. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Graphical Abstract An important regulator of innate immunity, the protein complex of Toll-like receptors 1 and 2 (TLR1/TLR2) provides an attractive target for the treatment of various immune disorders. The novel compound CU-CPT22 can compete with the binding of the specific lipoprotein ligand to TLR1/TLR2 (see picture) with high inhibitory activity and specificity. Repression of downstream signaling from TNF-α and IL-1β was also observed. Citing Literature Supporting Information Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors. Filename Description anie_201204910_sm_miscellaneous_information.pdf9.5 MB miscellaneous_information Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. Volume51, Issue49December 3, 2012Pages 12246-12249 RelatedInformation